Ornithine transcarbamylase deficiency (OTCD) is a type of urea cycle disorder – a disease in which the body fails to clear toxic ammonia from the bloodstream. The accumulation of ammonia in the blood (hyperammonaemia) can lead to potentially life-threatening metabolic disturbances in affected individuals, known as acute metabolic decompensation. Several factors, including infection, are thought to precipitate these metabolic aberrations. In this study, Peter McGuire and colleagues identify infection as the most common cause of acute decompensation in a prospective cohort of individuals with OTCD. To explore the metabolic changes that occur, they developed an experimental mouse model in which decompensation with hyperammonaemia is triggered by influenza infection. In response to infection, mice demonstrated altered hepatic immune function and reductions in urea cycle enzyme activity and urea cycle intermediates. These findings could help guide the development of new approaches to manage acute metabolic decompensation in OTCD and related inborn errors of metabolism. Page 205
- © 2014. Published by The Company of Biologists Ltd
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Other journals from The Company of Biologists
First person – Zhaoyang, Omkara, Christine and Yong
Catch up with our first authors in the latest interviews. Zhaoyang Liu, Omkara Lakshmi Veeranki, Christine Lehner and Yong Chen discuss the implications of their research, life as an early-career researcher and their next steps.
A new resource article by Dipen Maru's group describes a patient-derived orthotopic xenograft model of gastroesphageal cancer that maintains the morphological and molecular characteristics of the source tumour.
There are still funded places available for early-career researchers at July’s Workshop on inflammaging and regeneration! The deadline for applications is 14 February. We’re also interested to hear your ideas for Workshops – find out more about how we can provide support.
The first preLight of 2020 and the first time we’ve highlighted a medRxiv preprint! Zhang-He Goh discusses a new preprint by Witte et al. assessing the correlation between ovarian cancer patient-derived organoids and patients’ clinical response to chemotherapeutics.
Cover article – Regulation of terminal hypertrophic chondrocyte differentiation in Prmt5 mutant mice modeling infantile idiopathic scoliosis
On the cover, research by Liu et al. demonstrates that the loss of Prmt5 osteochondral progenitors impairs terminal hypertrophic chondrocyte differentiation, leading to defects in endochondral bone formation and models infantile idiopathic scoliosis in mouse.